Clinical Trial Update: Efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy in Patients With Stable Angina Pectoris [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Extracorporeal Shockwave Myocardial Revascularization Therapy for stable angina pectoris has completed and is reporting on efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina Pectoris

Drugs mentioned

• Extracorporeal Shockwave Myocardial Revascularization Therapy

Snippet

Sponsor: Evgeny Shkolnik, MD | Conditions: Stable Angina Pectoris | Phase 3 | Status: COMPLETED